AskBio to showcase cutting-edge research on AAV therapies and manufacturing advancements at ESGCT 2024
Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, will deliver 11 presentations offering insights into the research and development… read more.
